| 5.7°C Dublin

Fresh hope Pfizer Ireland developing Covid-19 vaccine that could be 'ready to go' within weeks

The two-dose vaccine, BNT162b2, has been tested on 35,000 people so far, with a total of 39,862 enrolled in the trials program so far.

Close

Vaccine (stock)

Vaccine (stock)

PA

Vaccine (stock)

Pfizer’s Ireland operations are at the forefront of a new Covid-19 vaccine that could be here within a matter of weeks, it has emerged. 

Ireland is on the list of countries that could get the vaccine if it first gets emergency use approval from the US’s Food and Drug Authorisation agency and the European Medicines Agency.

Even though FDA approval will not be sought until after the US presidential election, the processes could be completed in a matter of weeks.

The two-dose vaccine, BNT162b2, has been tested on 35,000 people so far, with a total of 39,862 enrolled in the trials program so far.

Paul Reid, managing director of Pfizer Ireland, said they could have 100 million doses ready by the end of 2020.

“If we have an advance purchase agreement with the EU Commission, that is secured,” he said.

“Part of that would include a volume we think we can make available across Europe.

"We are accelerating through the clinical trial programme at breakneck speed. We are seeing a speed of recruitment into the trials that we have never seen before.”

Pfizer Ireland, which has a huge plant in Cork, and its German partner BioNTech are emerging as the front-runners in the quest for a viable vaccine that could make the company billions.

Online Editors


Privacy